Dec 9, 2021
Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA), a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders, today announced its entry into an agreement with an investor to complete a non-brokered private placement (the “financing”) of a convertible secured subordinated debenture in the principal amount of C$5.5 million. According to the update, the financing is expected to close on Dec. 10, 2021. “I would like to thank our incredible strategic shareholder for stepping up in a tough, volatile market and continuing to support and expand upon your large stake in Mydecine,” said the company’s CEO Josh Bartch. “This financing will give Mydecine the runway needed to continue meeting important milestones like launching our smoking cessation study in partnership with Johns Hopkins University and PTSD (Post Traumatic Stress Disorder) studies with various global military focused organizations, furthering our drug development initiatives and growing paid subscribers on our telehealth platform Mindleap.”
To view the full press release, visit https://ibn.fm/BAItp
About Mydecine Innovations Group
Mydecine Innovations is a biotechnology and digital technology company developing innovative first- and second-generation novel therapeutics for the treatment of mental health and addiction through world-class technology and drug-development infrastructure. Mydecine was founded in 2020 on the guiding principle that there is a significant unmet need and lack of innovation in the mental health and therapeutic treatment environments. Mydecine Innovations Group is dedicated to efficiently developing innovative therapeutics to treat PTSD, depression, anxiety, addiction and other mental health disorders. The company’s business model combines clinical trials and data outcome, technology, and scientific and regulatory expertise with a focus on psychedelic therapy underpinned by other novel molecules with differentiated therapeutic potential. By collaborating with some of the world’s foremost authorities connected by best practices, Mydecine Innovations Group aims to responsibly fast-track the development of new medicines across its platforms, seeking to effectively treat and ultimately change the way mental health disorders are treated. Mydecine’s vision is to bridge the current gap between what the mental healthcare system currently provides with the needs of the patients. Mydecine is headquartered in Denver, Colorado, USA, with international offices in Leiden, Netherlands. For more information about the company, please visit www.Mydecine.com.
NOTE TO INVESTORS: The latest news and updates relating to MYCOF are available in the company’s newsroom at https://ibn.fm/MYCOF
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.PsychedelicNewsWire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
[email protected]
PsychedelicNewsWire is part of the InvestorBrandNetwork.
The jailed comedian’s statement, read aloud by his wife Laura Gallacher, has triggered a dispute between ministers and Google, while prison authorities investigate whether his public message breached regulations.
The Hollywood superstar is preparing to celebrate 30 years since his wrestling debut at Survivor Series in Houston, while also returning to his former university for a special ESPN appearance ahead of a major college football clash.
The Hollywood actor has opened up about reuniting with Sarah Jessica Parker, Luke Wilson and Rachel McAdams for a long-awaited sequel, more than 20 years after the original festive film became a Christmas favourite.
The Emmy-winning Welsh actor has recalled an awkward meeting with the Bond producers in London, where an unusual suggestion for the famous spy left the room silent before his career took a very different direction.
The 69-year-old singer has opened up about his four-year illness, surgery and radiation treatment, months after an alarming fall during a concert sparked concern among fans of the legendary Motown group.
The Spanish actress is reuniting with director Juan Diego Botto for a powerful new film exploring domestic violence and the justice system, while her performances in three other projects attract attention ahead of the 2027 Oscars.
The French actress has questioned whether younger actors have the depth to play the famous British spy while discussing Amazon's takeover, Denis Villeneuve's appointment and the future of the blockbuster franchise.
Brian Blessed has claimed female gorillas tried to "feel [him] up" after mistaking him for a potential mate during his frequent visits to a wildlife park, where he would wrestle an ape named George.
Erika Eleniak credits OnlyFans for saving her home after giving her a much-needed financial boost.
Kendall Jenner has "experienced so many red-flag men" and won't date anyone with an "ego" anymore.
Gracie Abrams went to hospital after experiencing panic attacks so severe, she thought she was "dying".
Martha Stewart thinks Cate Blanchett is the "perfect" choice to play her in a planned biopic.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.